PPD takes the initiative as new business drops off
This article was originally published in Scrip
Executive Summary
Pharmaceutical Product Development (PPD), a US contract research organisation (CRO), reported a decline in third-quarter profit compared with the same period last year owing to "lower-than-expected" new business.